Detalhe da pesquisa
1.
Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants.
N Engl J Med
; 388(11): 969-979, 2023 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36920755
2.
Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants. Reply.
N Engl J Med
; 388(26): 2491, 2023 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37379148
3.
Pharmacokinetic/pharmacodynamic and safety study of a single dose of evolocumab 140 mg in healthy Chinese subjects.
Int J Clin Pharmacol Ther
; 58(10): 557-564, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32729822
4.
An open-label study in healthy men to evaluate the risk of seminal fluid transmission of denosumab to pregnant partners.
Br J Clin Pharmacol
; 81(2): 362-9, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26447647
5.
Readiness of wait-listed black patients to pursue live donor kidney transplant.
Prog Transplant
; 24(4): 355-61, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25488559
6.
Safety and Tolerability of the APOL1 Inhibitor, Inaxaplin, following Single- and Multiple-Ascending Doses in Healthy Adults.
Glomerular Dis
; 4(1): 64-73, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38600955
7.
CaSR-mediated interactions between calcium and magnesium homeostasis in mice.
Am J Physiol Endocrinol Metab
; 304(7): E724-33, 2013 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23360827
8.
Romosozumab in Skeletally Mature Adults with a Fresh Unilateral Tibial Diaphyseal Fracture: A Randomized Phase-2 Study.
J Bone Joint Surg Am
; 102(16): 1416-1426, 2020 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32358413
9.
A Randomized, Placebo-Controlled Study of Romosozumab for the Treatment of Hip Fractures.
J Bone Joint Surg Am
; 102(8): 693-702, 2020 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31977817
10.
The full-length calcium-sensing receptor dampens the calcemic response to 1alpha,25(OH)2 vitamin D3 in vivo independently of parathyroid hormone.
Am J Physiol Renal Physiol
; 297(3): F720-8, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19474191
11.
The calcium-sensing receptor (CaSR) defends against hypercalcemia independently of its regulation of parathyroid hormone secretion.
Am J Physiol Endocrinol Metab
; 297(4): E915-23, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19797241
12.
Timing of sirolimus conversion influences recovery of renal function in liver transplant recipients.
Clin Transplant
; 23(6): 887-96, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19681971
13.
Influence of Renal Function on Evolocumab Exposure, Pharmacodynamics, and Safety.
Clin Pharmacol Drug Dev
; 8(3): 281-289, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30676701
14.
A Phase 1, Randomized, Double-Blind, Single-Dose, Placebo-Controlled Safety, Tolerability, And Pharmacokinetic/Pharmacodynamic Study Of Evolocumab In Healthy Chinese Subjects.
Clin Pharmacol
; 11: 145-153, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31695519
15.
Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations.
Best Pract Res Clin Rheumatol
; 22(1): 129-48, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18328986
16.
Rupture of an infected liver cyst into the pericardium in a kidney transplant recipient with polycystic kidney disease.
Am J Kidney Dis
; 49(6): 851-3, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17533028
17.
Pharmacokinetics, Biotransformation, and Excretion of [14C]Etelcalcetide (AMG 416) Following a Single Microtracer Intravenous Dose in Patients with Chronic Kidney Disease on Hemodialysis.
Clin Pharmacokinet
; 56(2): 179-192, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27517676
18.
Performance of the pegfilgrastim on-body injector as studied with placebo buffer in healthy volunteers.
Curr Med Res Opin
; 33(2): 379-384, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27819161
19.
Evaluation of Evolocumab (AMG 145), a Fully Human Anti-PCSK9 IgG2 Monoclonal Antibody, in Subjects With Hepatic Impairment.
J Clin Pharmacol
; 57(4): 513-523, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27667740
20.
A clinical therapeutic protein drug-drug interaction study: coadministration of denosumab and midazolam in postmenopausal women with osteoporosis.
Pharmacol Res Perspect
; 2(2): e00033, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25505582